Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1

NCT01430637 — Completed, 20 participants, Children's Oncology Group

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comprehensive Genome Sequencing of Desmoplastic Small Round Cell Tumors

RegistryNCT01430637
StatusCompleted
Study typeObservational
Enrollment20 (Estimated)
SponsorChildren's Oncology Group (Network); collaborators: National Cancer Institute (NCI)
ConditionsSarcoma
InterventionsDNA analysis, RNA analysis, gene expression analysis, mutation analysis, nucleic acid sequencing, polymerase chain reaction, laboratory biomarker analysis, pharmacogenomic studies (Genetic, other)
Datesstart 2011-09-01, primary completion 2016-05-01, first posted 2011-09-08, last updated 2016-05-18

Related Papers Related Patents Related Grants Related Experts
All trials for Sarcoma All trials of DNA analysis All trials of RNA analysis

-Summary

RATIONALE: Studying samples of blood and tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying genes in samples from younger patients with desmoplastic small round cell tumor registered on COG-D9902 or COG-ABTR01B1.

Expand all sections  ·  Collapse all

+Detailed description

OBJECTIVES:

* To perform whole-exome sequencing on desmoplastic small round cell tumor (DSRCT) samples and their available matched normal samples to identify novel mutations, single nucleotide polymorphisms, or copy number changes associated with these tumors.
* To identify regions of interest that may be involved in the pathogenesis (including the region of EWSR1-WT1 translocation) from the whole-exome sequencing and perform detailed resequencing and transcriptone sequencing to further define the molecular aberrations at the RNA level.

OUTLINE: This is a multicenter study.

Archived tumor tissue samples are analyzed for DNA sequencing, effects of RNA on gene expression levels, novel RNA isoforms, splice variants, and translocations.

+Arms and interventions

  • DNA analysis (Genetic)
  • RNA analysis (Genetic)
  • gene expression analysis (Genetic)
  • mutation analysis (Genetic)
  • nucleic acid sequencing (Genetic)
  • polymerase chain reaction (Genetic)
  • laboratory biomarker analysis (Other)
  • pharmacogenomic studies (Other)

+Outcome measures

Primary outcomes

  • Identification of novel mutations, single nucleotide polymorphisms, and copy number changes associated with DSRCT
  • Identification of genomic regions involved in pathogenesis of DSRCT

+Eligibility

Sex: All, ages: any to 50 Years

DISEASE CHARACTERISTICS:

* Tumor and blood samples from patients registered on COG-D9902 or COG-ABTR01B1 obtained from the Cooperative Human Tissue Network (CHTN) and the Children's Oncology Group (COG) tumor banks
* Matched normal samples

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified

+Investigators